Not applicableStudy completedNCT00348426What this trial is testingBotulism Outbreak in Thailand (Episode II)Who this might be right forBotulism Department of Medical Services Ministry of Public Health of Thailand 200
Testing effectiveness (Phase 2)Study completedNCT01252199What this trial is testingStudy of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2Who this might be right forShiga Toxin Producing Bacterial Infection Thallion Pharmaceuticals 45
Early research (Phase 1)Study completedNCT03035370What this trial is testingViaskin Pertussis Vaccine TrialWho this might be right forWhooping Cough DBV Technologies 102
Not applicableStudy completedNCT02055183What this trial is testingBT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum AntitoxinWho this might be right forBotulism Emergent BioSolutions 162
Testing effectiveness (Phase 2)Study completedNCT00350298What this trial is testingStudy of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated DiseaseWho this might be right forClostridium Infections MassBiologics 200
Early research (Phase 1)Study completedNCT02531685What this trial is testingPhase 1 Study of dmLT ID Vaccination in Healthy AdultsWho this might be right forGastroenteritis Escherichia Coli National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT02296320What this trial is testingStudy of the Efficacy and Safety of MEDI4893Who this might be right forStaphylococcus Aureus Pneumonia MedImmune LLC 213
Testing effectiveness (Phase 2)Study completedNCT01770743What this trial is testingSafety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose LevelsWho this might be right forAnthrax Emergent BioSolutions 168
Not applicableLooking for participantsNCT07250724What this trial is testingC. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.Who this might be right forClostridioides Difficile Infection Recurrence Bactolife A/S 60
Post-approval studies (Phase 4)UnknownNCT03088111What this trial is testingAn Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. AnthracisWho this might be right forInfection, BacterialAnthrax Elusys Therapeutics 100
Early research (Phase 1)Study completedNCT04171115What this trial is testingStudy to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult SubjectsWho this might be right forHealthy Alachua Government Services, Inc. 40
Post-approval studies (Phase 4)WithdrawnNCT06237465What this trial is testingBotulinum Toxin-A for Hidradenitis SuppurativaWho this might be right forHidradenitis SuppurativaHidradenitis Suppurativa \(HS\)Hidradenitis Suppurativa, Acne Inversa Yale University
Large-scale testing (Phase 3)Study completedNCT01125527What this trial is testingImmunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy ChildrenWho this might be right forHaemophilus Influenzae Type b (Hib) Infection Novartis Vaccines 700
Not applicableStudy completedNCT02968758What this trial is testingValidation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile StrainsWho this might be right forClostridium Difficile Infection Meridian Bioscience, Inc. 2,461
Testing effectiveness (Phase 2)Study completedNCT02946190What this trial is testingThe PertADO Geneva TrialWho this might be right forPertussis Siegrist Claire-Anne 60
Not applicableUnknownNCT02910791What this trial is testingThe Role of Bacterial Toxins in Human Skin DiseaseWho this might be right forAtopic DermatitisPsoriasis National Jewish Health 100
Not applicableStudy completedNCT01406288What this trial is testingOutbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4Who this might be right forHemolytic-uremic SyndromeEscherichia Coli Infections University Hospital, Bordeaux 9
Post-approval studies (Phase 4)Not Yet RecruitingNCT02177721What this trial is testingClinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure ScenarioWho this might be right forInfections, Bacterial Emergent BioSolutions 100
Early research (Phase 1)Not Yet RecruitingNCT07649096What this trial is testingA Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides DifficileWho this might be right forClostridium Difficile Infection National Institute of Allergy and Infectious Diseases (NIAID) 86
Early research (Phase 1)Study completedNCT01769417What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult SubjectsWho this might be right forStaphylococcus Aureus MedImmune LLC 85